出版國家:England
出版周期:雙月刊
影響因子:2.621
研究領(lǐng)域: 藥物評價、藥物治療、藥物制劑、產(chǎn)品上市后監(jiān)管
5年影響因子:2.43
國外數(shù)據(jù)庫收錄:IM,2.621" />
Expert Opinion on Drug Safety (ISSN 1474-0338 [print], 1744-764X [electronic]) is a MEDLINE-indexed,peer-reviewed, international journal publishing review articles on all aspectsof drug safety and original papers on the clinical implications of drugtreatment safety issues, providing expert opinion on the scope for futuredevelopment.
TheEditors welcome:
Reviews covering occurrence, management and prevention of drug-associated adverseevents; risk-benefit analyses of individual drugs and drug classes; safety in'at-risk' patient populations; comparative tolerability studies;pharmacovigilance and pharmacoepidemiological studies
DrugSafety Evaluations reviewing thesafety data on a particular drug
OriginalResearch papers reporting the resultsof post-marketing surveillance and other safety studies looking at specificdrugs, populations and outcomes; methods for the detection and evaluation ofdrug-associated adverse events